Qvanteq AG
8005 Zürich, Technoparkstrasse 1 / Transfer Nord 2021
+41 44 500 98 90
info@qvanteq.com
Development and manufacturing of bioactive vascular stents to restore flow in diseased blood vessels.
Qvanteq AG
Technoparkstrasse 1
8005 Zürich
3 Ergebnisse für "hyperplasia" unter Qvanteq AG
Qstent – Qvanteq
... reduced neointimal hyperplasia and improved endothelialization compared to commercially available and ... combinations. Animal studies conducted by CBSET ( www.cbset.org ) showed reduced neointimal hyperplasia and ...
Mechanism of Action – Qvanteq
... as: low thrombogenicity, increased speed of endothelialization and reduced neointimal hyperplasia. ... endothelialization and reduced neointimal hyperplasia. Recent News Qvanteq ISO13485:2016 re-certification In ...
ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
6 Ergebnisse für "hyperplasia" unter ETH Zürich - Numerische Materialmodellierung
Research – Institute of Biochemistry | ETH Zurich
... Research Nutrient restriction (NR) causes a shift from hypertrophy to hyperplasia in PTEN mutant ... ) causes a shift from hypertrophy to hyperplasia in PTEN mutant cells Tumor cells evade the breaks imposed ...
Research – Laboratory of Translational Nutrition Biology | ETH Zurich
... is achieved through hypertrophy and hyperplasia. Whereas adipocyte hypertrophy (increase in size) is ... strongly associated with insulin resistance and local tissue inflammation, hyperplasia (increase in number ... is achieved through hypertrophy and hyperplasia. Whereas adipocyte hypertrophy (increase in size) is ... strongly associated with insulin resistance and local tissue inflammation, hyperplasia (increase in number ...
